Prof. Dr. med. Michael von Bergwelt

internal medicine, hematology, oncology, infectiology, intensive care, and emergency medicine

User Score	Experience	Rating	Price Range	Publications	Media Files	Online Consultations
96%	30 years	9.8/10	$$$$	582	9	No

Overview

Country, City

Germany, Munich

Health facility

University Hospital Ludwig-Maximilians Munich

Medical unit

Clinic and policlinic of internal medicine III (Oncology and Hematology)

About the doctor

Prof. Dr. med. Michael von Bergwelt is a highly experienced doctor with extensive expertise in internal medicine, hematology, oncology, infectiology, intensive care, and emergency medicine. He currently works at the University Hospital Ludwig-Maximilians in Munich, Germany, in the Department of Oncology. Along with his extensive education and certifications, Prof. Dr. von Bergwelt has made significant contributions to medical research with over several hundred scientific publications. His expertise and focus on tumor immunotherapy and precision oncology make him a valuable asset in cancer treatment. Notably, he has been involved in research on CAR-T cells in melanoma and immune checkpoint inhibition in Hodgkin lymphoma. Prof. Dr. von Bergwelt's dedication to advancing medical knowledge and his commitment to patient care have earned him recognition, including prestigious awards such as the Mildred-Scheel Fellowship from the German Cancer Aid. With his vast experience and innovative research efforts, Prof. Dr. med. Michael von Bergwelt is a trusted and accomplished doctor in his field.

Skills & Expertise

Gallery

Motivation Health - Prof. Dr. med. Michael von Bergwelt

Prof. Dr. Dr. Michael von Bergwelt: Return to normality only through collective immunity

EuroCARTForce: a platform for progress

Ask Oncology: Immunotherapy

Learnings from a CAR-T center: leukapheresis, bridging therapy, toxicities & more

Increase in cancer patient transfers to the ICU: what does it come down to?

Resume

CV (Curriculum Vitae)

Education

1988-1996 Medicine at the University of Freiburg, University of Munster, and Paris-Sud University
1994-1996 Human biology at the Paris-Sud University
1996 Approbation in medicine
1996 Master of biological and medical sciences
1996 United States medical licensure examination parts I/II
1997 Dissertation (M.D.) in University of Freiburg: „Phenotypical and functional characterization of tumor-infiltrating lymphocytes in colorectal carcinoma under stimulation with Interleukin-2 and Interleukin-4 in vitro”
1999 Board certification in emergency medicine, Lower Saxony
1999-2002 PostDoc, Dana-Farber Cancer Institute, Harvard Medical School Boston
2001 Fellow, Lymphoma Research Foundation of America
2002 Fellow, German Jose Carreras Leukemia Foundation
2002 Dissertation (Ph.D.) with distinction, University of Oldenburg: “Biological and Biotechnological Analyses on CD40-activated B cells as Antigen Presenting Cells”
2006 Board certification in internal medicine, hematology, and oncology
2007 Habilitation in internal medicine: „Analysis of the antigen-presenting function of B cells: translation to tumor immunotherapy”
2008 Board certification in intensive care medicine
2009 Board certification in infectiology

Experience

1997-1999 Internship, Department I of internal medicine, University of Cologne (Prof. Volker Diehl)
2002-2007 Internship and fellowship, Department I of internal medicine, University of Cologne (Prof. Michael Hallek)
2003-2009 Head, Max-Eder Junior Research Group, German Cancer Aid
2007 Consultant at the Department I of internal medicine, University of Cologne (Director Prof. M. Hallek)
2008 Scientific Director, Department I of internal medicine, the University of Cologne (Director Prof. M. Hallek)
2008 Director, Cologne Interventional Immunology
2011 Senior Consultant
2012 Adjunct Professor of internal medicine, University of Cologne
2015 Coordinating Investigator, CARTime Research Consortium, CAR-T cells in a melanoma-clinical trial, Federal Ministry of Education and Research of Germany
2016 Head tumor immunology, Research Consortium Immune checkpoint inhibition in Hodgkin lymphoma
2017 Professor, Department of oncology at University Hospital of the Ludwig-Maximilians University Munich

Awards & Memberships

1997 Mildred-Scheel Fellow, German Cancer Aid
1999 Scientific Award European Medical Students' Association, University of Prague
1999 Travel Award of the American Society of Hematology
2010 Travel Award, American Society for Blood and Marrow Transplantation
2010 Basic Science Award, European Society for Blood and Marrow Transplantation
2015 Best Abstract Award, German Society for Haematology and Medical Oncology